Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema.
about
Acute-phase protein α1-anti-trypsin: diverting injurious innate and adaptive immune responses from non-authentic threatsExpanding the clinical indications for α(1)-antitrypsin therapyDeficiency of α-1-antitrypsin influences systemic iron homeostasisA review of augmentation therapy for alpha-1 antitrypsin deficiency.Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesisAlpha-1 Antitrypsin Deficiency PI*Z and PI*S Gene Frequency Distribution Using on Maps of the World by an Inverse Distance Weighting (IDW) Multivariate Interpolation Method.Effect of recombinant α1-antitrypsin Fc-fused (AAT-Fc)protein on the inhibition of inflammatory cytokine production and streptozotocin-induced diabetes.The design of a new truncated and engineered alpha1-antitrypsin based on theoretical studies: an antiprotease therapeutics for pulmonary diseases.Alpha-1 antitrypsin: a potent anti-inflammatory and potential novel therapeutic agent.Role of cockroach proteases in allergic disease.Twenty years of polymers: a personal perspective on alpha-1 antitrypsin deficiency.Alpha-1 antitrypsin deficiency: new developments in augmentation and other therapies.Neutrophilic panniculitis associated with alpha-1-antitrypsin deficiency: an update.Recent advances in understanding and treating COPD related to α1-antitrypsin deficiency.Clinical utility of alpha-1 proteinase inhibitor in the management of adult patients with severe alpha-1 antitrypsin deficiency: a review of the current literature.Successful α1-antitrypsin replacement therapy in a patient with α1-antitrypsin deficiency and granulomatosis with polyangiitis.The important role of primary care providers in the detection of alpha-1 antitrypsin deficiency.High-density lipoproteins potentiate α1-antitrypsin therapy in elastase-induced pulmonary emphysema.Well-Known and Less Well-Known Functions of Alpha-1 Antitrypsin. Its Role in Chronic Obstructive Pulmonary Disease and Other Disease Developments.Rare case of eosinophilic granulomatosis with polyangiitis in two patients with α-1-antitrypsin deficiency (PiSZ).Alpha-1 Antitrypsin Inhibits ATP-Mediated Release of Interleukin-1β via CD36 and Nicotinic Acetylcholine Receptors.
P2860
Q26858837-E1FC1449-2887-474D-BD14-8E2B6E6C08F7Q27000764-01F948FA-6E14-4B23-975D-38861DE4DC32Q28393697-DCFB7740-5AC9-4D52-A121-D61D5AA280F3Q34268108-57BF299C-F4A1-4651-9A34-40F934A75312Q35233352-2187CFD4-D3C6-44D8-8E68-5CA3F200BD6DQ36407173-CC640A07-B5F8-4F89-8898-77F8E21867B4Q36885672-0406A0EE-F37F-4E88-B68E-5CF7FB7BD7DCQ36972809-F078E57D-A21B-4354-B1F9-D0FD81F256B8Q37986292-0EEA7F3D-5929-46B6-966A-03696B81F767Q38014360-707C5FE9-2AD5-4E9C-BD86-6FB3882A5E24Q38092851-4C9808F1-A784-4AC9-8AB3-C5CB51DD2625Q38114852-BF5D01E9-08B4-4560-8270-64EA9462A3C9Q38643507-D9CCA36D-E50B-44C3-A1FC-BFCD82739AACQ38988633-A0606953-73C6-437E-B30C-A197121B80FEQ41138327-5B5798EF-65E6-4D71-8364-E22C2F0F7388Q45142383-55C14FBE-0E05-400F-ACF2-12A9E5905901Q47683303-63666F43-F984-489A-967D-87F24A2F5037Q47747847-F9D2D375-B627-4779-8280-1D023FD24680Q51465416-B84679CC-2049-4BA7-BF92-6C5F132474ECQ51529985-C6C299D5-6027-4FB7-B40F-C2E25D51F1F0Q55261353-973E590E-3B96-4067-8653-DD6DB430EEB1
P2860
Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Efficacy of alpha1-antitrypsin ...... ther than pulmonary emphysema.
@ast
Efficacy of alpha1-antitrypsin ...... ther than pulmonary emphysema.
@en
Efficacy of alpha1-antitrypsin ...... ther than pulmonary emphysema.
@nl
type
label
Efficacy of alpha1-antitrypsin ...... ther than pulmonary emphysema.
@ast
Efficacy of alpha1-antitrypsin ...... ther than pulmonary emphysema.
@en
Efficacy of alpha1-antitrypsin ...... ther than pulmonary emphysema.
@nl
prefLabel
Efficacy of alpha1-antitrypsin ...... ther than pulmonary emphysema.
@ast
Efficacy of alpha1-antitrypsin ...... ther than pulmonary emphysema.
@en
Efficacy of alpha1-antitrypsin ...... ther than pulmonary emphysema.
@nl
P2093
P2860
P921
P356
P1476
Efficacy of alpha1-antitrypsin ...... ther than pulmonary emphysema.
@en
P2093
Beatriz Lara
Frederick de Serres
Ignacio Blanco
P2860
P2888
P356
10.1186/1750-1172-6-14
P5008
P577
2011-04-12T00:00:00Z
P5875
P6179
1040270682